#10 | Early diagnosis procedures: Lung cancer | By Cancer Education and Research Institute (CERI)
#10 | Early diagnosis procedures: Lung cancer | By Cancer Education and Research Institute (CERI)
In this episode we discuss early detection procedures for lung cancer. Please also check Episode #2 on cancer stages
Disclaimer: We can not assume responsibility of misinterpretation of content.
In this episode we discuss early detection procedures for lung cancer. Please also check Episode #2 on cancer stages
Disclaimer: We can not assume responsibility of misinterpretation of content.
FDA APPROVALS for LUNG CANCER
December 12, 2022: FDA grants accelerated approval to adagrasib for KRAS G12C-mutated NSCLC
The Food and Drug Administration (FDA) granted accelerated approval to adagrasib (Krazati, Mirati Therapeutics, Inc.), a RAS GTPase family inhibitor, for adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy.
Read more here.
Read more here.
